Recognising a lifetime of achievement
Lung Foundation Australia has proudly welcomed four new members into our lifetime achievement award club. All four recipients have made significant contributions to helping people living with lung disease across Australia.
COPD National Program member and former Lung Foundation Australia Board Member, David Hayne, joined the organisation as a consumer representative for the COPD Coordinating Committee in 2004. A consultant pharmacist who cared for his wife, Kate, a COPD patient and lung transplant recipient, David was a consistent advocate for practical actions that would benefit those with lung disease. In 2012, David became the inaugural chair of the Pharmacy Sub Committee of the COPD National Program and oversaw the development of our online training program for pharmacists.
Dr John Litt, GP and 14-year member of our Lung Cancer National Program, is a keen and well-respected clinician, teacher, mentor and researcher. He was a key member of the team that developed the Lung Cancer Guidelines and Assessment and Management of Lung Cancer guide for GPs.
Dr Peter Cole is a respiratory physician and was a 14-year member of our Lung Cancer National Program as an inaugural member of the Lung Cancer Consultative Group. Peter wrote a book that captured the stories of those with lung cancer who had surgery and were living well, which he used as a resource for other lung cancer patients facing surgery. Peter retired from Gold Coast Hospital and the Lung Cancer Consultative Group in 2015 to focus his humanitarian work in Noumea and New Caledonia.
Perth lung cancer patient, advocate and fundraiser, Sandy Sampson, has been an amazing supporter of Lung Foundation Australia since her own diagnosis in July 2011. She has been a passionate advocate raising awareness of the lack of lung cancer research funding and a keen supporter of our Shine a Light on lung cancer events. In 2013, Sandy organised a lung cancer fundraising calendar that highlighted the lighter and human side of living with lung cancer.